Status:
COMPLETED
UNITE Study (UMN-GE) for COVID-19
Lead Sponsor:
University of Minnesota
Collaborating Sponsors:
General Electric Research
DARPA (Department of Defense)
Conditions:
Covid19
Cytokine Storm
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The research objective of the UNITE Study is to assess device feasibility of ultrasound application to the spleen to assess its effect on coronavirus disease 2019 (COVID-19) in a pilot study with an o...
Detailed Description
Ultrasound is widely used in human medicine because it is safe, non-invasive, and painless. The same kind of ultrasound that is used for imaging (for example, to visualize babies in utero) may be able...
Eligibility Criteria
Inclusion
- Age 18 and above
- Positive for SARS-CoV-2 (via PCR)
- Decreased blood oxygen saturation: Room air SaO2 \< 94% and/or requiring supplemental oxygen to maintain SaO2 \> 90%
- Admission to the hospital
Exclusion
- Pregnant women
- Asplenia
- Ascites
- Open wound/sores near the stimulation site
- Recent abdominal surgery
- Splenomegaly
- Mechanically ventilated (if patient goes onto mechanical ventilation while participating in the study, they can continue ultrasound treatment if recommended by standard of care clinician and investigators of the study)
- Comfort care status
- Any other clinical reasons deemed by the investigators of the study in which the patient would not be an appropriate candidate for the study
Key Trial Info
Start Date :
January 14 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 7 2021
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04701489
Start Date
January 14 2021
End Date
April 7 2021
Last Update
May 3 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
M Health Fairview St. Joseph's Hospital
Saint Paul, Minnesota, United States, 55102